diuride - 10 tablet
global pharma healthcare pvt. ltd+saga a-9, sidco pharmaceutical complex, alathur, - torsemide tablets - tablet - 10 mg - other high-ceiling diuretics
diuride-20 tablet
global pharma healthcare pvt. ltd+saga a-9, sidco pharmaceutical complex, alathur, - torsemide usp - tablet - 20 mg - high-ceiling diuretics: plain sulfonamides
metzole intravenous infusion injection
global pharma healthcare pvt.ltd a-9 sidco pharmaceutical complex, alathur, - metronidazole - injection - 500mg/100ml - metronidazole
razid - 20 tablet
global pharma healthcare pvt. ltd+saga a-9, sidco pharmaceutical complex, alathur, - rabeprazole sodium - tablet - 20mg - drugs for peptic ulcer and gastro-oesophageal
razid - m capsule
global pharma healthcare pvt. ltd+saga a-9, sidco pharmaceutical complex, alathur, - rabeprazole sodium & mosapride citrate sustained - capsule - rabeprazole sodium 20mg mosapride citrate 15mg - drugs for functional gastrointestinal disorders:
sterile water for injection
global pharma healthcare pvt.ltd. a-9 sidco pharmaceutical complex, alathur, - sterile water - injection - - - all other non-therapeutic products: solventsand
zyrtal od tablet
global pharma healthcare pvt. ltd+saga a-9, sidco pharmaceutical complex, alathur, - aceclofenac bp - tablet - 200 mg - non-steroidal
zyrtal sp tablet
global pharma healthcare pvt. ltd+saga a-9, sidco pharmaceutical complex, alathur, - aceclofenac and serratiopeptidase - tablet - aceclofenac 100mg serratiopeptidase 15mg - anti-inflammatory/antirheumatic agents in
gloace-100 film-coated tablet
global pharma healthcare pvt ltd c/o medox po box 52771 - 00200 - aceclofenac - film-coated tablet - aceclofenac 100mg - aceclofenac
voriconazole pharma regulatory solutions 200 milligram pdr for soln for infusion
pharma regulatory solutions ltd - voriconazole - pdr for soln for infusion - 200 milligram - triazole derivatives - antimycotics for systemic use, triazole derivatives - voriconazole is a broad-spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows: treatment of invasive aspergillosis. treatment of candidaemia in non-neutropenic patients. treatment of fluconazole-resistant serious invasive candida infections (including c. krusei). treatment of serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.